Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and type 2 diabetes
2008-003954-13Phase 2Completed
- Sponsor
- Regionshospitalet Silkeborg
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vitamin d in type 2 diabetes mellitus (T2DM) and Vitamin D deficiency (VDD), sponsored by Regionshospitalet Silkeborg. Primary endpoint: Insulin secretion and insulin sensitivity. Started Aug 2008; status: completed.
02
Drugs
vitamin d
03
Conditions
type 2 diabetes mellitus (T2DM)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2008-003954-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003954-13.